Skip to main content
Premium Trial:

Request an Annual Quote

U. of Liverpool Awarded $33.5M to Build Personalized Medicine Incubator Space

NEW YORK (GenomeWeb) – The University of Liverpool said on Wednesday that it has been awarded about £20.5 million ($33.5 million) to build an incubator space for small and medium-sized businesses operating in the personalized medicine arena.

The Liverpool Bio Innovation Hub will encompass more than 6,000 square meters and will include laboratory and office space, allowing commercial access to biobank technologies and genomic, proteomic, and metabolomic equipment.

Munir Pirmohamed, head of the Wolfson Centre for Personalised Medicine, said in a statement that the Bio Hub will facilitate collaboration between the university, the UK's National Health Service partners, and industry "to ensure that medical research is translated effectively into outputs that will benefit patients. It provides industry with access to expertise, biosamples, and high-end equipment, as well as opportunities for researchers to work with commercial enterprises."

The space is anticipated to open next year.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.